|

ART6043 Clinical Trials

1 actively recruiting trial across 1 location

Pipeline

Phase 1/2: 1

Top Sponsors

  • Artios Pharma Ltd1

Indications

  • Metastatic Solid Tumor1
  • Advanced Solid Tumor1
  • Breast Cancer1
  • Cancer1

Grand Rapids, Michigan1 trial

Study of ART6043 in Advanced/Metastatic Solid Tumors Patients (POLKA)

South Texas Accelerated Research Therapeutics (START) - Midwest

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.